These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 2119091

  • 1. [The protease inhibitor gabexate mesilate in experimentally-induced acute pancreatitis with early gram-negative infection in the Göttingen minipig: therapeutic efficacy and effects on blood coagulation and fibrinolysis].
    Heitz J, Semsch B, Emde C, Jansen U, Schäfer JH.
    Z Gastroenterol; 1990 Apr; 28(4):192-7. PubMed ID: 2119091
    [Abstract] [Full Text] [Related]

  • 2. [Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients].
    Freise J, Melzer P, Schmidt FW, Horbach L.
    Z Gastroenterol; 1986 Apr; 24(4):200-11. PubMed ID: 3087076
    [Abstract] [Full Text] [Related]

  • 3. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
    Nishiyama T, Kohno Y, Koishi K.
    Am J Emerg Med; 2012 Sep; 30(7):1219-23. PubMed ID: 22204993
    [Abstract] [Full Text] [Related]

  • 4. Effects of protease inhibitors on coagulation abnormalities in acute canine pancreatitis.
    Izquierdo R, Sandberg L, Squillaci G, Hoppensteadt D, Walenga J, Fareed J, Prinz R.
    Am Surg; 1984 Jun; 50(6):317-23. PubMed ID: 6203448
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of nafamostat mesilate (FUT-175) and gabexate mesilate (FOY) on multiorgan oxidant-antioxidant balance in acute experimental pancreatitis.
    Dabrowski A, Gabryelewicz A.
    J Physiol Pharmacol; 1994 Sep; 45(3):455-65. PubMed ID: 7841457
    [Abstract] [Full Text] [Related]

  • 8. [Effects of the synthetic proteinase inhibitor, FOY, on hypercoagulability after surgery for esophageal carcinoma].
    Usuba A, Motoki R, Koizumi Y, Oishi A, Endo Y, Konno O, Inoue H.
    Nihon Geka Gakkai Zasshi; 1990 Aug; 91(8):931-41. PubMed ID: 2122227
    [Abstract] [Full Text] [Related]

  • 9. Synthetic antiproteases in acute pancreatitis: an experimental study.
    Dobosz M, Sledziński Z, Babicki A, Juszkiewicz P, Basiński A, Wajda Z.
    Mt Sinai J Med; 1992 Jan; 59(1):43-6. PubMed ID: 1734237
    [Abstract] [Full Text] [Related]

  • 10. Does gabexate mesilate affect serum concentrations of acute phase proteins after endoscopic retrograde cholangiopancreatography examination?
    Pezzilli R, Gabbrielli A, Labate AM, D'Alessio P, Barakat B, Costamagna G, Dibenedetti F, Massa M, Merlini G, d'Eril GM.
    Hepatogastroenterology; 2003 Jan; 50(51):851-5. PubMed ID: 12828103
    [Abstract] [Full Text] [Related]

  • 11. Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction.
    Chen HM, Chen JC, Hwang TL, Jan YY, Chen MF.
    Hepatogastroenterology; 2000 Jan; 47(34):1147-50. PubMed ID: 11020900
    [Abstract] [Full Text] [Related]

  • 12. Effects of gabexate mesilate (FOY) on ischemia-reperfusion-induced acute lung injury in dogs.
    Luh SP, Tsai CC, Shau WY, Chen JS, Kuo SH, Lin-Shiau SY, Lee YC.
    J Surg Res; 1999 Dec; 87(2):152-63. PubMed ID: 10600344
    [Abstract] [Full Text] [Related]

  • 13. Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma.
    Chen CL, Wang SD, Zeng ZY, Lin KJ, Kao ST, Tani T, Yu CK, Wang JY.
    J Allergy Clin Immunol; 2006 Jul; 118(1):105-12. PubMed ID: 16815145
    [Abstract] [Full Text] [Related]

  • 14. The influence of a serine protease inhibitor, nafamostat mesilate, on plasma coagulation, and platelet activation during experimental Extracorporeal Life Support (ECLS).
    Mellgren K, Skogby M, Friberg LG, Tengborn L, Wadenvik H.
    Thromb Haemost; 1998 Feb; 79(2):342-7. PubMed ID: 9493588
    [Abstract] [Full Text] [Related]

  • 15. Gabexate mesilate improves pancreatic microcirculation and reduces lung edema in a rat model of acute pancreatitis.
    Chen HM, Shyr MH, Chen MF.
    J Formos Med Assoc; 1997 Sep; 96(9):704-9. PubMed ID: 9308324
    [Abstract] [Full Text] [Related]

  • 16. Gabexate mesilate and camostate: new inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis.
    Freise J, Schmidt FW, Magerstedt P, Schmid K.
    Clin Biochem; 1985 Aug; 18(4):224-9. PubMed ID: 2412725
    [Abstract] [Full Text] [Related]

  • 17. Prevention of the spread of experimental acute pancreatitis by intraductal administration of a synthetic protease inhibitor in dogs.
    Wakayama T, Itoh T, Shibayama K, Idezuki Y.
    Am J Gastroenterol; 1989 Mar; 84(3):272-8. PubMed ID: 2465686
    [Abstract] [Full Text] [Related]

  • 18. Extracorporeal anticoagulation using a serine protease inhibitor in hemodialysis in sheep.
    Mottaghy K, Oedekoven B, Bey R, Schmid-Schönbein H.
    Trans Am Soc Artif Intern Organs; 1985 Mar; 31():534-6. PubMed ID: 3939276
    [No Abstract] [Full Text] [Related]

  • 19. Effect of nafamostat mesilate on coagulation and fibrinolysis in hepatic resection.
    Shimada M, Matsumata T, Shirabe K, Kamakura T, Taketomi A, Sugimachi K.
    J Am Coll Surg; 1994 May; 178(5):498-502. PubMed ID: 8167888
    [Abstract] [Full Text] [Related]

  • 20. Fatal cases of gabexate mesilate-induced anaphylaxis.
    Matsukawa Y, Nishinarita S, Sawada S, Horie T.
    Int J Clin Pharmacol Res; 2002 May; 22(3-4):81-3. PubMed ID: 12837044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.